8-K
filed February 26, 2026, 6:59 PM ET
ticker MNKD
CIK 0000899460
earnings
confidence high
sentiment positive
materiality 0.75
MannKind Q4 revenue $112M (+46% YoY); Furoscix adds $23M in first quarter
MANNKIND CORP
2025-FY EPS reported
$0.02
revenue$348,966,000
- Total revenues $112M in Q4 2025, up 46% vs Q4 2024; full-year revenues $349M, up 22%.
- Afrezza net sales $23M in Q4, +25% YoY; Furoscix net sales $23M since acquisition Oct 7, 2025.
- PDUFA target dates: Afrezza pediatric sBLA May 29, 2026; Furoscix ReadyFlow sNDA July 26, 2026.
- R&D expense $27.6M (+148% YoY); SG&A $58.4M (+144%) driven by Furoscix and launch prep.
- Cash & investments $176M at Dec 31, 2025; scPharmaceuticals acquisition completed Oct 7.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-073509
- form_type
- 8-K
- ticker
- MNKD
- cik
- 0000899460
- company_name
- MANNKIND CORP
- filed_at
- 2026-02-26T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:37.993191+00:00
- generated_at
- 2026-05-15T23:59:25.001036+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-073509
- json_url
- https://secwatch.observer/filing/0001193125-26-073509.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-073509.md
- text_url
- https://secwatch.observer/filing/0001193125-26-073509.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/899460/000119312526073509/0001193125-26-073509-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/899460/000119312526073509/mnkd-20260226.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
YSWY
Yesway reports Q1 net income $30.2M, Adjusted EBITDA $59.2M; introduces FY2026 outlook
Yesway, Inc.
June 2, 2026, 7:35 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
VSCO
Victoria's Secret Q1 sales up 15% to $1.56B, beats guidance; raises FY2026 outlook
Victoria's Secret & Co.
June 2, 2026, 7:01 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
CTRN
Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M
Citi Trends Inc
June 2, 2026, 6:58 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SIG
Signet Q1 sales $1.6B, SSS +1.8%; raises FY27 adjusted EPS guidance
SIGNET JEWELERS LTD
June 2, 2026, 6:54 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DG
Dollar General Q1 EPS $2.00 beats expectations; raises FY2026 EPS guidance
DOLLAR GENERAL CORP
June 2, 2026, 6:54 AM ET
earnings
Items 2.02, 5.07, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
HIVE
HIVE FY2026 revenue $297.8M (+158% YoY); GAAP net loss $148.4M
HIVE Digital Technologies Ltd.
June 2, 2026, 6:23 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DCI
Donaldson Q3 FY2026 sales $995.1M (+5.8%), adj. EPS $1.06 (+7.1%)
DONALDSON Co INC
June 1, 2026, 5:41 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
GMRS
GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B
GMR Solutions Inc.
June 1, 2026, 4:45 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.